M8 Pharmaceuticals Overview
- Founded
-
2007
- Status
-
Private
- Employees
-
301
- Latest Deal Type
-
2ndary - Private
- Investors
-
5
M8 Pharmaceuticals General Information
Description
Provider of specialty pharmaceutical services intended to focus on the commercialization of innovative and established therapeutics in Latin American markets. The company's services are provided by partnering with pharmaceutical companies looking to establish, maintain or expand their business presence due to their understanding of the regulatory complexities, stringent quality assurance and adherence to international standards, enabling people to get innovative and proven therapies.
Contact Information
Website
www.m8pharmaceuticals.com
Formerly Known As
Moksha8 Pharmaceuticals
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Other Pharmaceuticals and Biotechnology
Other Healthcare Services
Primary Office
- 1055 Westlakes Drive
- Suite 300
- Berwyn, PA 19312
- United States
+1 (610) 000-0000
M8 Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Secondary Transaction - Private | 00000 | Completed | Generating Revenue | |||
| 11. Mezzanine | 15-Feb-2019 | 0000 | 00000 | Completed | Generating Revenue | |
| 10. Later Stage VC | 06-Jan-2014 | 00000 | Cancelled | Generating Revenue | ||
| 9. Later Stage VC (Series 3) | 01-Nov-2012 | 0000 | 00000 | Completed | Generating Revenue | |
| 8. Secondary Transaction - Private | 22-Oct-2012 | 000.00 | 00000 | Completed | Generating Revenue | |
| 7. Later Stage VC (Series C) | 14-Oct-2010 | 0000 | 00000 | 00000 | Completed | Startup |
| 6. Early Stage VC | 10-Jun-2010 | 00.00 | 000.00 | Completed | Startup | |
| 5. Early Stage VC (Series B) | 01-Dec-2009 | 000.00 | 000.00 | 000.00 | Completed | Startup |
| 4. Early Stage VC | 05-Nov-2009 | $5M | $50.9M | Completed | Startup | |
| 3. Early Stage VC | 11-Feb-2009 | $6.86M | $45.9M | Completed | Startup |
M8 Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series 3a | 00,000,000 | 00.000000 | 0.00 | 00.0 | 00.0 | 00.0 | 00.000 | |
| Series 3a | 00,000,000 | 00.000000 | 0.00 | 00.00 | 00.00 | 00.00 | 0.000 | |
| Series 2 | 00,000,000 | 00.000000 | 0.00 | 00.00 | 00.00 | 00.00 | 00.000 | |
| Series 1a | 1,858,968 | $0.001000 | 9.5% | $3.29 | $3.29 | $3.29 | 1.25% | |
| Series 1 | 18,706,466 | $0.001000 | 9.5% | $0.9 | $0.9 | $0.9 | 12.59% |
M8 Pharmaceuticals Executive Team (17)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Joel Barlan | Chief Executive Officer & Board Member | ||
| Rogelio Sandoval | Chief Financial Officer | ||
| Saulo Xavier | Chief Compliance Officer | ||
| Rafael Ferrer | Vice President of corporate development | ||
| Stig Pedersen | Executive Chairman |
M8 Pharmaceuticals Board Members (12)
| Name | Representing | Role | Since |
|---|---|---|---|
| Arthur Higgins | Self | Board Member | 000 0000 |
| Daniel Turner III | Montreux Equity Partners | Board Member | 000 0000 |
| Joel Barlan | M8 Pharmaceuticals | Chief Executive Officer & Board Member | 000 0000 |
| Mariano García-Valiño | Self | Board Member | 000 0000 |
| Stig Pedersen | Self | Executive Chairman | 000 0000 |
M8 Pharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
M8 Pharmaceuticals Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| TPG Biotechnology Partners | Other | Minority | 000 0000 | 000000 0 | |
| Montreux Equity Partners | Growth/Expansion | Minority | 000 0000 | 000000 0 | |
| Aragen Life Sciences | PE-Backed Company | Minority | 000 0000 | 000000 0 | |
| Lit Tele | Corporation | Minority | 000 0000 | 000000 0 | |
| TPG | PE/Buyout | Minority | 000 0000 | 000000 0 |